Divi's Labs Faces Rs 570 Crore Tax Adjustment Proposal in Draft IT Order, Plans Appeal Written By Parthika Patel24 March 2026 11:25 AM ISTNew Delhi: Divi's Laboratories Limited has received a draft assessment order from the Income Tax Authority proposing additions/disallowances amounting...
MHT CET Reopens BPharm Registration Window for 2026 Written By Parthika Patel24 March 2026 10:30 AM ISTMumbai: The Maharashtra State Common Entrance Test (MHT CET) Cell has reopened the registration window for BPharm courses for the 2026 session,...
Gilead to Acquire Ouro Medicines in USD 2 Billion Deal to Boost Immunology Pipeline Written By sheeba farhat24 March 2026 10:15 AM ISTBengaluru: Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth more than USD 2 billion to expand...
Alkem Gets EU GMP Compliance Certificate for Daman Facility from Malta Authority Written By Parthika Patel23 March 2026 4:15 PM ISTNew Delhi: Alkem Laboratories Limited has received a Certificate of GMP Compliance of a Manufacturer from the Malta Medicines Authority for its...
Eris Lifesciences Acquires Velbiom's Probiotic Portfolio for Rs 50 Crore Written By Parthika Patel23 March 2026 3:00 PM ISTMumbai: Eris Lifesciences Limited has announced the acquisition of the branded probiotic business of Velbiom Probiotics Private Limited through a...
USFDA Flags Seizure Risk in Parkinson's Drugs, Orders Label Updates Written By sheeba farhat23 March 2026 11:45 AM ISTBengaluru: The U.S. Food and Drug Administration said on ​Friday it has notified ​manufacturers of certain Parkinson's disease treatments to update...
Roche Drops Muscle Disease Drug After Trial Failure Written By sheeba farhat23 March 2026 11:30 AM ISTBengaluru: Roche has stopped developing its experimental drug for two rare muscle diseases after it failed to show meaningful benefits, the Swiss...
Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma Written By sheeba farhat23 March 2026 11:15 AM ISTBengaluru: The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination treatment for adults and adolescents...
CDSCO Flags Illegal Manufacturing of Sodium Hyaluronate Eye Drops, Seeks Immediate Action Written By Susmita Roy22 March 2026 6:15 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has directed all State and Union Territory Drugs Controllers to take immediate...
CDSCO Panel Recommends Key Changes in Phase III Study of Glimepiride-Linagliptin FDC Written By Susmita Roy22 March 2026 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report for Glimepiride 1 mg/2 mg plus Linagliptin 5 mg/5 mg Tablets, the Subject Expert...
Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical Devices Rules Written By Susmita Roy22 March 2026 5:45 PM ISTNew Delhi: The Ministry of Health and Family Welfare has issued a notification to further amend the Medical Devices Rules, 2017, introducing specific...
Cipla Announces Leadership Change, USD 100 Million Investment, Approves Inzpera Merger Written By Parthika Patel22 March 2026 1:27 PM ISTNew Delhi: Cipla Limited has announced key board decisions including leadership changes, a USD 100 million investment in its subsidiary, and approval...
